Blood Flow The Way It Should Be™ VentriFlo is a novel, truly pulsatile blood pump designed to achieve superior outcomes. Not currently available for human use.
VentriFlo is moving ahead toward FDA approval with regulatory guidance by @AvaniaClinical. VentriFlo, Inc. CEO Doug Vincent, "Avania has become a critical strategic partner in helping prepare the VentriFlo® True Pulse Pump for successful market clearance". linkedin.com/feed/update/urn…
VentriFlo, Inc., is proud to announce we've been selected by MIT as one of just 16 MIT-related companies to participate in MIT-Columbia Venture Pitch Day, October 10, 2019 in New York City. We hope to significantly accelerate development and FDA approval #VentriFlo#CPB#ECMO
Design Mentor was nominated by MIT to compete to be one of 16 MIT-related companies to take part in October’s MIT-Columbia Venture Pitch Day in front of 1,000 VCs to accelerate VentriFlo’s innovative blood pump technology. #VentriFlo#CPB#ECMO
infomeddnews.com/ventriflo-a…
Really exciting news!
VentriFlo® True Pulse Pump and the logo are registered trademarks of Design Mentor, Inc.
VentriFlo is sponsored in part by the National Capital Consortium for Pediatric Surgical Innovation, and is not cleared for human use.
"...we are incredibly proud to have been so honored, especially among this year’s terrific competition. This [$100k] represents the first portion of our critical First-in-Human funding ... Thank you.” Doug Vincent, CEO Design Mentor, VentriFlo developer. bit.ly/TechOut2018
#TechOut2018 winners announced: @TendoNova takes home $150,000 for first place, @VentriFlo takes home $100,000 for second place and @The_Cyborg_Lab takes home $50,000 in investment capital prizes. Congratulations! bit.ly/2BcVHLP
Three companies won investment capital at tonight’s #TechOut2018 competition. @The_Cyborg_Lab won $50k, @VentriFlo won $100k and @TendoNova won $150k. Congratulations to all!